JENNIFER PETERSON: Open Payments
NPI 1427510437 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,014 in 31 payments from 13 companies in 2025. Trend: 2023 $657 · 2024 $1,587 · 2025 $1,014
Food & beverage: $1,014
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $203 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $164 |
| Vanda Pharmaceuticals Inc. | 6 | $150 |
| Indivior Inc. | 2 | $144 |
| ABBVIE INC. | 2 | $87 |
| Almatica Pharma LLC | 3 | $73 |
| Biogen, Inc. | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Orexo US, Inc. | 1 | $24 |
Products named: CAPLYTA, LYBALVI, SUBLOCADE, FANAPT, VRAYLAR, LOREEV XR, ARISTADA, ZURZUVAE.
Industry payments across AZ — which companies pay providers there.
